Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 09-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||
| Net Income | -12,200 | -9,038 | -6,880 |
| Depreciation Amortization | 60 | 32 | 4 |
| Accounts payable and accrued liabilities | N/A | 705 | N/A |
| Other Working Capital | 1,690 | 1,327 | -2,280 |
| Other Operating Activity | 740 | 144 | 1,116 |
| Operating Cash Flow | $-9,710 | $-6,831 | $-8,040 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -880 | -265 | -130 |
| Investing Cash Flow | $-880 | $-265 | $-130 |
| Cash Flows From Financing Activities | |||
| Debt Issued | N/A | 3,000 | N/A |
| Other Financing Activity | 16,470 | -956 | 15,890 |
| Financing Cash Flow | $16,470 | $2,044 | $15,890 |
| Beginning Cash Position | 7,850 | 7,858 | 140 |
| End Cash Position | 13,720 | 2,806 | 7,850 |
| Net Cash Flow | $5,870 | $-5,052 | $7,710 |
| Free Cash Flow | |||
| Operating Cash Flow | -9,710 | -6,831 | -8,040 |
| Capital Expenditure | N/A | -265 | N/A |
| Free Cash Flow | -9,710 | -7,096 | -8,040 |